In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1857 News Items found
An illustration of a samurai and a crab.
In the Lab
Ro Versus Musashi: How One Molecule Can Turn Cancer Cells Back to Normal

Researchers identify a compound that appears to eliminate tumor cells in a dish and in mice.
Doctor with back to camera speaking with smiling girl.
In the Clinic
Proton Therapy: A Safer Way to Eliminate Tumors in Kids

Proton therapy offers a way to treat pediatric cancers more safely.
Immune cells surrounding a cancer cell
In the Lab
Checkpoint Challenge: When Releasing Immune Cell Brakes Is Not Enough to Stop Cancer

Scientists have learned that cutting a T cell’s brakes can have unexpected consequences.
MSK patient Kara Kenny hugging medical oncologist Diane Reidy Lagunes
Feature
Coping with Rectal Cancer: A Young Mother’s Story of Determination and Compassion

Learn how MSK is helping a young mother cope with rectal cancer through the Center for Young Onset Colorectal Cancer, the first program in the country devoted to younger adults with this disease.
MSK-ACCESS Receives New York State Approval for New Molecular Assay

Memorial Sloan Kettering Cancer Center (MSK) today announced that the New York State Department of Health has issued approval for a new molecular assay, Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).  MSK-ACCESS was developed within the Marie-Josee and Henry R. Kravis Center for Molecular Oncology (CMO) and the test has been clinically validated and implemented by members of MSK’s Molecular Diagnostics Service.
Two clusters of colored blobs with a diagram in the middle
In the Lab
Computational “Hive Mind” Helps Scientists Solve an Enzyme’s Cryptic Movements

The breakthrough gives an unprecedented look at the varied and shifting poses of a protein in action.
People milling about at the 2019 ASCO meeting
Roundup
Highlights from ASCO 2019: A Low-Fat Diet and Breast Cancer Risk, Targeted Therapy for Salivary Gland Tumors, and More

Read about a few of the MSK studies being presented at the 2019 American Society of Clinical Oncology's annual meeting.
Crowd shot at ASCO 2019
Roundup
Highlights from ASCO 2019: Progress in Treating Cancer in Children

MSK Kids doctors report advances in treating pediatric cancers at the 2019 meeting of the American Society of Clinical Oncology.
MSK medical oncologist Eileen O'Reilly with a patient
In the News
ASCO 2019: PARP Inhibitors Benefit People with Pancreatic Cancer Who Have a BRCA Mutation

Results from a large phase III clinical trial unveiled at this year’s ASCO meeting identify an effective targeted therapy for a subset of people with pancreatic cancer.
Medical oncologist William Tap
Q&A
What Can Be Learned from a Negative Clinical Trial? Findings from a Sarcoma Study at ASCO 2019

At the ASCO meeting in Chicago, MSK medical oncologist William Tap talked about disappointing results from a new sarcoma drug, which didn’t increase survival.